Frontlight ResearchEarly access
Chronic spontaneous urticaria trials in Netherlands
3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Enrolling by invitationLong-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
- Where
- Utrecht
- Age
- 18 years and over
- People
- 1,370 worldwide
- Run by
- Celldex Therapeutics
See details and how to joinNCT07256392 - Phase 3Taking peopleLong-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Where
- Amsterdam, Utrecht
- Age
- 18 years and over
- People
- 438 worldwide
- Run by
- Celldex Therapeutics Inc.
See details and how to join2025-522878-36-00 - No phaseTaking peopleSKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 840
- Run by
- Leiden University Medical Center
See details and how to joinNCT07021495